Image

Proving Utility of a New Field-cycling MRI Prototype in Acute Stroke Patients

Proving Utility of a New Field-cycling MRI Prototype in Acute Stroke Patients

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can show changes in the brain within the first day of a stroke due to a blocked blood vessel or bleeding in the brain. The main question it aims to answer is:

• Can FCI identify brain tissue that might recover within the first few hours after a stroke begins?

Participants will undergo a standard MRI scan and an FCI scan, as soon as possible after hospital admission.

Participants who have had a blocked blood vessel will also provide a blood sample and will have a follow up visit at 30 days for repeat of both scans and providing another blood sample.

Eligibility

Inclusion Criteria:

  • Acute stroke (\<24 hours from symptom onset).
  • NIHSS ≥4 and \<25 with cortical involvement and/or large vessel occlusion on baseline imaging.
  • Able to undergo 3T and FCI MRI \<24h of onset.
  • With or without thrombolysis.

Exclusion Criteria:

  • Contraindications to MRI.
  • Medically unstable.
  • Unable to comprehend or comply with instructions regarding scanning
  • Prior mRS of \>3.
  • Identified for thrombectomy.
  • Non-stroke pathology or previous cortical infarct on CT scan \> 1/3 of middle cerebral artery territory.

Study details
    Stroke Acute

NCT07004140

University of Aberdeen

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.